Price Alert

Evogene Ltd. (EVGN)

NASDAQ: EVGN · Real-Time Price · USD

1.31

0.09 (7.38%)

At close: Aug 21, 2025, 3:59 PM

1.31

0.00%

After-hours: Aug 21, 2025, 06:35 PM EDT

Evogene Statistics

Share Statistics

Evogene has 8.71M shares outstanding. The number of shares has increased by 31.9% in one year.

Shares Outstanding	8.71M
Shares Change (YoY)	31.9%
Shares Change (QoQ)	24.35%
Owned by Institutions (%)	7.75%
Shares Floating	8.58M
Failed to Deliver (FTD) Shares	3,039
FTD / Avg. Volume	0.16%

Short Selling Information

The latest short interest is 174.43K, so 2% of the outstanding shares have been sold short.

Short Interest	174.43K
Short % of Shares Out	2%
Short % of Float	2%
Short Ratio (days to cover)	2.45

Valuation Ratios

The PE ratio is -0.65 and the forward PE ratio is -0.79. Evogene's PEG ratio is 0.01.

PE Ratio	-0.65
Forward PE	-0.79
PS Ratio	1.25
Forward PS	0.8
PB Ratio	-7.34
P/FCF Ratio	-0.52
PEG Ratio	0.01

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Evogene.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.15, with a Debt / Equity ratio of -8.87.

Current Ratio	1.15
Quick Ratio	1.06
Debt / Equity	-8.87
Debt / EBITDA	-0.83
Debt / FCF	-0.63
Interest Coverage	-179.11

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$72.74K
Profits Per Employee	$-140.9K
Employee Count	117
Asset Turnover	0.21
Inventory Turnover	1.47

Taxes

Income Tax	9K
Effective Tax Rate	-0.05%

Stock Price Statistics

The stock price has increased by -63.1% in the last 52 weeks. The beta is 1.58, so Evogene's price volatility has been higher than the market average.

Beta	1.58
52-Week Price Change	-63.1%
50-Day Moving Average	1.34
200-Day Moving Average	1.41
Relative Strength Index (RSI)	48.88
Average Volume (20 Days)	1,850,167

Income Statement

In the last 12 months, Evogene had revenue of 8.51M and earned -16.48M in profits. Earnings per share was -2.89.

Revenue	8.51M
Gross Profit	5.83M
Operating Income	-22.21M
Net Income	-16.48M
EBITDA	-15.48M
EBIT	-17.98M
Earnings Per Share (EPS)	-2.89

Full Income Statement

Balance Sheet

The company has 15.3M in cash and 12.87M in debt, giving a net cash position of 2.43M.

Cash & Cash Equivalents	15.3M
Total Debt	12.87M
Net Cash	2.43M
Retained Earnings	-274.07M
Total Assets	34.3M
Working Capital	902K

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -19.7M and capital expenditures -626K, giving a free cash flow of -20.33M.

Operating Cash Flow	-19.7M
Capital Expenditures	-626K
Free Cash Flow	-20.33M
FCF Per Share	-3.57

Full Cash Flow Statement

Margins

Gross margin is 68.48%, with operating and profit margins of -260.96% and -193.69%.

Gross Margin	68.48%
Operating Margin	-260.96%
Pretax Margin	-212.02%
Profit Margin	-193.69%
EBITDA Margin	-181.86%
EBIT Margin	-260.96%
FCF Margin	-238.82%

Dividends & Yields

EVGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for EVGN is $3.5, which is 167.2% higher than the current price. The consensus rating is "Buy".

Price Target	$3.5
Price Target Difference	167.2%
Analyst Consensus	Buy
Analyst Count	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Jul 25, 2024. It was a backward split with a ratio of 1:10.

Last Split Date	Jul 25, 2024
Split Type	backward
Split Ratio	1:10

Scores

Altman Z-Score	-12.39
Piotroski F-Score	2